RxDoctor Payments Data

Ashley Murphy

Family · Grandview, MONPI 1831642743

Payments from drug & device makers

$5,855in general payments, 2019–2025

Across 374 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$533
  • Lilly USA, LLC$472
  • Pfizer$434
  • AstraZeneca$375
  • Amgen$283
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,855100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,855 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$33,936
Medicare patients
80
Services billed
1,121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide74$102,471
OzempicSemaglutide60$69,906
JardianceEmpagliflozin42$59,206
EliquisApixaban35$25,929
FarxigaDapagliflozin Propanediol11$13,778
Tresiba Flextouch U-200Insulin Degludec12$10,455
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,529
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,423
Breo ElliptaFluticasone/Vilanterol12$4,887
ArexvyRsvpref3 Antigen/As01e/Pf15$3,515
Atorvastatin Calcium256$2,226
Rosuvastatin Calcium194$1,740
Omeprazole108$1,615
Duloxetine Hcl79$1,587
Levothyroxine Sodium161$1,246

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$472$102,47174 claims
Novo NordiskOzempic$533$69,90660 claims
Boehringer IngelheimJardiance$203$59,20642 claims
GSKAnoro Ellipta, Trelegy Ellipta, Breo Ellipta, Arexvy$237$26,35460 claims
PfizerEliquis$434$25,92935 claims
AstraZenecaFarxiga$375$13,77811 claims
AbbVieSynthroid$1,332$1,20313 claims
Almatica Pharma LLCSertraline Hcl$13$1,01680 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Grandview

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →